CRBU
Price
$1.99
Change
-$0.27 (-11.95%)
Updated
Nov 13 closing price
Capitalization
184.85M
122 days until earnings call
Intraday BUY SELL Signals
IGC
Price
$0.36
Change
-$0.01 (-2.70%)
Updated
Nov 13 closing price
Capitalization
32.74M
3 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs IGC

Header iconCRBU vs IGC Comparison
Open Charts CRBU vs IGCBanner chart's image
Caribou Biosciences
Price$1.99
Change-$0.27 (-11.95%)
Volume$1.92M
Capitalization184.85M
IGC Pharma
Price$0.36
Change-$0.01 (-2.70%)
Volume$572.54K
Capitalization32.74M
CRBU vs IGC Comparison Chart in %
CRBU
Daily Signal:
Gain/Loss:
IGC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRBU vs. IGC commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and IGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CRBU: $2.26 vs. IGC: $0.37)
Brand notoriety: CRBU and IGC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 55% vs. IGC: 50%
Market capitalization -- CRBU: $184.85M vs. IGC: $32.74M
CRBU [@Biotechnology] is valued at $184.85M. IGC’s [@Biotechnology] market capitalization is $32.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileIGC’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • IGC’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRBU and IGC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while IGC’s TA Score has 3 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 5 bearish.
  • IGC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than IGC.

Price Growth

CRBU (@Biotechnology) experienced а +3.20% price change this week, while IGC (@Biotechnology) price change was -6.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 16, 2026.

IGC is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($185M) has a higher market cap than IGC($32.7M). CRBU YTD gains are higher at: 42.138 vs. IGC (8.929). IGC has higher annual earnings (EBITDA): -6.36M vs. CRBU (-150.76M). CRBU has more cash in the bank: 184M vs. IGC (454K). IGC has less debt than CRBU: IGC (202K) vs CRBU (25.9M). CRBU has higher revenues than IGC: CRBU (9.12M) vs IGC (1.33M).
CRBUIGCCRBU / IGC
Capitalization185M32.7M566%
EBITDA-150.76M-6.36M2,371%
Gain YTD42.1388.929472%
P/E RatioN/AN/A-
Revenue9.12M1.33M687%
Total Cash184M454K40,529%
Total Debt25.9M202K12,822%
FUNDAMENTALS RATINGS
IGC: Fundamental Ratings
IGC
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUIGC
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
IGC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBVA21.830.38
+1.77%
Banco Bilbao Vizcaya Argentaria SA
OLED120.921.55
+1.30%
Universal Display Corp
BRY3.40-0.04
-1.16%
Berry Corp
RES5.50-0.18
-3.17%
RPC
BEEM1.86-0.28
-13.08%
Beam Global

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+0.89%
CRSP - CRBU
61%
Loosely correlated
-5.47%
MGNX - CRBU
54%
Loosely correlated
-3.29%
BEAM - CRBU
53%
Loosely correlated
-2.71%
RXRX - CRBU
52%
Loosely correlated
-1.27%
SYRE - CRBU
52%
Loosely correlated
+0.34%
More

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
-5.35%
TECX - IGC
49%
Loosely correlated
-0.63%
ANVS - IGC
30%
Poorly correlated
+15.17%
ARTL - IGC
29%
Poorly correlated
-8.16%
KZR - IGC
28%
Poorly correlated
-0.32%
CRBU - IGC
28%
Poorly correlated
+0.89%
More